Efficacy and safety of perioperative sintilimab plus platinum-based chemotherapy for potentially resectable stage IIIB non-small cell lung cancer (periSCOPE): an open-label, single-arm, phase II trialResearch in context

Summary: Background: The absolute overall survival (OS) improvement with preoperative chemotherapy or chemoradiotherapy in locally advanced non-small cell lung cancer (NSCLC) patients is controversial and unsatisfactory. We designed this trial to explore the efficacy and safety of perioperative sin...

Full description

Bibliographic Details

Published in:	EClinicalMedicine
Main Authors:	Xiangyang Yu, Chujian Huang, Longde Du, Chunguang Wang, Yikun Yang, Xin Yu, Shengcheng Lin, Chenglin Yang, Hongbo Zhao, Songhua Cai, Zhe Wang, Lixu Wang, Xiaotong Guo, Baihua Zhang, Zhentao Yu, Jie He, Kai Ma
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Subjects:	Perioperative chemoimmunotherapy Potentially resectable IIIB Non-small cell lung cancer Sintilimab
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537024005765